RAPPORT THERAPEUTICS INC. - COMMON STOCK

16,69

08-января-25 15:45:00

15 мин. задержка

Акции

-1,10

-6,16%

Сегодняшний диапазон

16,34 - 17,53

ISIN

N/A

Источник

NASDAQ

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 янв 2025 08:12:59 Источник Nasdaq GlobeNewswire
Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire
Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

06 дек 2024 11:01:00 Источник Nasdaq GlobeNewswire
Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

14 ноя 2024 06:00:02 Источник Nasdaq GlobeNewswire
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

07 ноя 2024 06:00:01 Источник Nasdaq GlobeNewswire
Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

04 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

05 сен 2024 06:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.